Showing results (1-10 of 286) with videos related to

Sort By:
Pageof 29
Nouvelle Revue Francaise D'Hematologie|August 1, 1993
Plasma erythropoietin in essential thrombocythaemiaJ J Viala, D Ville, C Sebban, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase II trial of plicamycin and hydroxyurea in acute myelogenous leukemiaE Archimbaud, J Troncy, C Sebban, et al.
Haemostasis|January 1, 1990
Increased plasma tissue-type plasminogen activator levels in patients with chronic thrombocytopeniaM Hanss, D Ville, M Dechavanne
Thrombosis and Haemostasis|November 24, 1989
Aggregation to thrombin and collagen of platelets from a Glanzmann thrombasthenic patient lacking glycoproteins IIb and IIIaL McGregor, M Hanss, A Sayegh, et al.
The Journal of Investigative Dermatology|March 1, 1982
Clearance mediated by splenic macrophage membrane receptors for immune complexes in cutaneous vasculitisC Dambuyant, J Thivolet, J J Viala, et al.
American Journal of Hematology|April 1, 1995
Design and validation of a bedside decision instrument to elicit a patient's preference concerning allogenic bone marrow transplantation in chronic myeloid leukemiaC Sebban, G Browman, A Gafni, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1981
[Pure red cell aplasia and chronic leukemia. Usefulness of ferrokinetic measurements (author's transl)]J J Viala, D Ville, B Coiffier, et al.
Blood|November 1, 1987
Intensive chemotherapy in aggressive lymphomas: updated results of LNH-80 protocol and prognostic factors affecting response and survivalB Coiffier, P A Bryon, M Ffrench, et al.
Leukemia|August 1, 1992
Continuous-infusion daunorubicin and carboplatin for high-risk acute myeloid leukemia in the elderlyE Archimbaud, B Anglaret, X Thomas, et al.
Cancer Treatment Reports|June 1, 1987
Influence of daunorubicin and cytarabine sequencing on the outcome of therapy in acute myelogenous leukemia: a randomized trialE Archimbaud, D Fiere, D Treille-Ritouet, et al.
Pageof 29